Ulrich Medical ECONOMIC

Target: Ulrich Medical / ulrich GmbH & Co. KG Research date: 28 October 2026 Research domain: Economic Geographic focus: Israel, the West Bank including East Jerusalem, and the Golan Heights Evidence standard: Publicly retrievable documentation; historical relationships distinguished from currently observable disclosures.

Supply Chain & Sourcing Relationships

Direct supplier relationships

Ulrich Medical is a German medical-device manufacturer whose published product portfolio includes spinal implants, radiology contrast-media injectors, and associated medical equipment; its product categories and procurement disclosures do not establish agricultural sourcing relationships.^{1, 2}

No public evidence identified of Ulrich Medical purchasing agricultural products from Mehadrin, Hadiklaim, Galilee Export, Agrexco successors, or other named Israeli agricultural suppliers.^{1, 3}

Israeli distribution relationship

Gil Medical Group identifies Ulrich as a commercial partner on a dedicated page within its corporate website, providing direct public evidence of an Israeli commercial intermediary associated with the Ulrich brand.⁴

Gil Medical also includes Ulrich Medical among the partner brands displayed on its homepage and in its partner directory, confirming that the relationship is publicly represented across multiple pages of the same distributor’s website.^{5, 6}

Gil Medical states that it has operated in Israel since 1972 and offers nationwide distribution and customer-support services, including round-the-clock support.⁵

Gil Medical identifies its location as 21 Gonen Street, Kiryat Matalon, Petach Tikva, Israel, and names Limor Rachmin as its import manager.⁷

An independently hosted Israeli medical-supplier directory identifies GIL MEDICAL LTD as an Israeli supplier located at Gonen 21, Petach Tikva, with Yehuda Gil and Tali Gil-Kamir named as management contacts.⁸

The Gil Medical relationship was publicly observable on 28 October 2026; its original commencement date, exclusivity, contractual duration, sales value, and precise product coverage could not be established from the retrieved partner listing.⁴

Act record - Israeli commercial representation

• Acting entity: Gil Medical Group / Gil Medical Ltd; associated manufacturer: Ulrich Medical / ulrich GmbH & Co. KG; recipient or beneficiary: Gil Medical’s Israeli medical-equipment customer market; channel: gilmedical.co.il, the Israeli distributor’s own website; earliest dated observation: not established; latest observation: 28 October 2026; status: publicly listed as an Ulrich partner at the research date, while current contractual performance remains unverified; communication audience: visitors to Gil Medical’s public website; publication duration: unknown.^{4, 5, 8}

Importer-of-record structure

Gil Medical publicly identifies dedicated import management, regulatory affairs, procurement, logistics, and customer-service functions, but its disclosure does not identify the importer of record for individual Ulrich products.⁷

No public evidence identified establishing that Ulrich Medical owns Gil Medical, operates an Israeli import subsidiary, or uses a separately incorporated Israeli joint venture as its importer of record.^{4, 8, 9}

Third-party and indirect distribution

Ulrich Medical states that its international commercial model includes exclusive specialist distributors operating across more than 50 export countries, with direct subsidiaries in selected major markets.⁹

Its international service documentation directs overseas customers to qualified local distributors for equipment support, repairs, technical safety inspections, software updates, and product installation.¹⁰

The Gil Medical listing is evidence of an Israeli third-party commercial channel, but the retrieved material does not establish whether every Israeli Ulrich transaction passes through Gil Medical or whether other intermediaries also participate.^{4, 10}

Other documented distribution relationships

Synapse Medical states that it distributes Ulrich Medical products throughout Ireland and the United Kingdom and identifies Hugo Technologies as a technical-service partner supporting its UK activities.¹¹

In an announcement concerning 2025 sales, Synapse Medical stated that it was Ulrich Medical’s third-largest global distributor and identified itself as part of Uniphar Medtech.¹²

Ulrich Medical identified GE Healthcare and Bracco Imaging as global collaborators in its July 2024 management announcement.¹³

These disclosures establish international commercial relationships but do not identify Israeli transactions conducted through Synapse Medical, GE Healthcare, Bracco Imaging, or Uniphar Medtech.^{11, 12, 13}

Act record - other international distribution

• Acting entity: Synapse Medical; associated manufacturer: Ulrich Medical; recipient: Irish and UK medical-equipment customers; channel: synapsemedical.ie and synapsemed.co.uk; earliest dated relationship observation: Synapse describes UK expansion beginning in 2016, although the exact Ulrich contract commencement date is unstated; latest observation: October 2026; status: publicly represented as continuing; audience: healthcare procurement and diagnostic-imaging customers.^{11, 12, 14}

Seasonal sourcing patterns

No public evidence identified of recurring seasonal procurement by Ulrich Medical from Israeli suppliers, including December–April agricultural sourcing arrangements.^{1, 3}

Product Origin, Labeling & Regulatory Compliance

Manufacturing origin

Ulrich Medical’s corporate history identifies Ulm, Germany, as the company’s longstanding headquarters and manufacturing location, with the business founded in 1912.¹⁵

The company describes its international product and manufacturing approach as centered on German medical-technology development and manufacturing, with additional product development in the United States.¹⁶

In June 2025, Ulrich Medical announced the opening of approximately 1,200 square meters of additional manufacturing space near Ulm for contrast-media injector production, following an opening ceremony on 27 May 2025.¹⁷

The April 2026 corporate update confirmed that manufacturing had commenced at the additional Dornstadt facility in May 2025 and described further production-capacity development at the Jungingen location.¹⁸

Act record - manufacturing expansion

• Acting entity: ulrich GmbH & Co. KG; beneficiary: the company’s radiology manufacturing operations; activity: additional contrast-media injector production capacity; location: Dornstadt near Ulm, Germany; channel: ulrichmedical.com corporate announcement; earliest dated observation: 27 May 2025; latest dated confirmation: 23 April 2026; status: production described as operational; audience: customers, employees, suppliers, and general corporate stakeholders.^{17, 18}

Settlement-origin products

No public evidence identified of Ulrich-branded products manufactured in Israeli settlements or of goods supplied by Ulrich Medical that were confirmed to originate in the West Bank, Jordan Valley, East Jerusalem, or Golan Heights.^{9, 15, 16}

Country-of-origin labeling compliance

No public evidence identified of an enforcement action, customs finding, or regulatory citation against Ulrich Medical concerning the country-of-origin labeling of settlement-produced goods.^{1, 9}

Corporate labeling policy

No public evidence identified of a corporate sourcing or labeling policy specifically addressing goods manufactured in Israeli settlements or internationally recognized occupied territories.^{1, 9}

Regulatory status

The company states that its CT motion, Max, uCentum, uBase, and neon3 product families obtained relevant European MDR certification during 2024.¹⁵

No public evidence identified establishing a specific Israeli product-registration number, Israeli medical-device marketing authorization, or Israeli regulatory enforcement action concerning Ulrich Medical.^{4, 7, 15}

Investment, Capital & Financial Exposure

Foreign direct investment

Ulrich Medical publicly identifies operating subsidiaries in the United States, France, and Spain; its published international locations overview does not identify an Israeli operating subsidiary.⁹

The company’s US subsidiary was established in 2006, its French subsidiary in 2017, and its Spanish subsidiary in 2024.^{9, 19}

No public evidence identified of Ulrich Medical acquiring or controlling an Israeli manufacturer, technology company, healthcare provider, distributor, real-estate company, or other Israeli operating enterprise.^{9, 16, 19}

Acquired Israeli subsidiaries

No public evidence identified of an acquired Israeli operating subsidiary or an Israeli company in which Ulrich Medical holds a controlling ownership interest.^{9, 16, 19}

Consequently, no verified Israeli acquisition date, purchase price, controlled manufacturing facility, subsidiary workforce, subsidiary revenue, or subsidiary-specific military or settlement relationship could be established.^{9, 16, 19}

Documented acquisition and asset-transfer activity outside Israel

Ulrich Medical announced in September 2024 that its longstanding Spanish distributor EuroAutomation was transferring its contrast-media injector business to the newly founded ulrich medical España through an asset transaction.²⁰

The Spanish subsidiary was founded on 10 July 2024, and Ulrich stated that its direct Spanish sales operation would begin on 1 October 2024.²⁰

Act record - Spanish asset transaction

• Acting entity: ulrich GmbH & Co. KG / ulrich medical España; counterparty: EuroAutomation; beneficiary: the newly established Spanish sales operation; activity: transfer of the Spanish injector business through an asset deal; channel: ulrichmedical.com; earliest dated transaction disclosure: 24 September 2024; planned direct-sales commencement: 1 October 2024; status: subsequently corroborated as an operating Spanish subsidiary; transaction value: not disclosed; communication audience: Ulrich’s public corporate-news readership.^{20, 21}

Research and development investment

Ulrich Medical’s US locations disclosure states that its American subsidiary develops products tailored to the US market, while implants are manufactured in Germany.¹⁹

No public evidence identified of an Ulrich-owned Israeli R&D center, Israeli innovation laboratory, Israeli accelerator investment, or equity-funded research operation.^{9, 19}

Parent and beneficial ownership

The company’s legal imprint identifies ulrich GmbH & Co. KG as the German operating entity and ulrich Verwaltungs GmbH as its personally liable corporate partner.²²

The same imprint identifies Christoph Ulrich as managing partner and Friedrich von Rechteren and Gordon Bittig as senior executives.²²

Ulrich Medical describes itself as a privately held family-owned company, with the Ulrich family maintaining management involvement across multiple generations.²³

The reviewed sources do not identify an Israeli parent, Israeli controlling shareholder, Israeli private-equity sponsor, or Israeli beneficial owner of Ulrich Medical.^{22, 23}

Shareholdings and controlling principals

Christoph Ulrich is publicly identified as managing partner, but the available corporate imprint does not disclose his exact percentage interest or a complete limited-partner ownership schedule.²²

No individual equity holder meeting a confirmed 10 percent ownership threshold could be enumerated with a verified percentage from the reviewed public disclosures.^{22, 23}

No public evidence identified of a material personal or family-office investment in Israeli companies attributable to Christoph Ulrich, Friedrich von Rechteren, Gordon Bittig, Klaus Kiesel, or other named Ulrich executives.^{22, 24}

Portfolio and fund exposure

No public evidence identified of direct Ulrich Medical holdings in Israeli sovereign debt, Israel Bonds, Israeli-domiciled listed companies, Israel-focused investment funds, or Israeli financial-sector entities.^{22, 23}

Financing the Israeli state

Ulrich Medical’s public corporate profile identifies medical-device manufacturing and distribution as its activities, rather than sovereign-debt underwriting, asset management, insurance, or banking.^{1, 23}

No public evidence identified of Ulrich Medical underwriting Israeli sovereign bonds, distributing Israel Bonds, financing Israeli defense contractors, or providing financial services to settlement-related entities.^{1, 22, 23}

Spain’s official Commercial Registry Gazette (Boletín Oficial del Registro Mercantil, BORME) confirms 10 July 2024 as the establishment/commencement date of ulrich medical España S.L. Entry 387474, published on 9 September 2024, records the company’s incorporation under “Constitución” and specifies “Comienzo de operaciones: 10.07.24”. The incorporation was registered in Madrid on 2 September 2024, under registration M 830698, entry 1. The record identifies ulrich GmbH & Co. KG as the sole shareholder and declares initial capital of EUR 200,000. This independently confirms the existing audit statement, “The Spanish subsidiary was founded on 10 July 2024,” under “Documented acquisition and asset-transfer activity outside Israel”. It also supports the audit’s distinction between legal establishment on 10 July 2024 and the separately announced commencement of direct Spanish distribution on 1 October 2024. The BORME record does not independently establish the October distribution launch; its July date concerns the registered company’s commencement of operations. No correction to the existing founding-date statement is required.²⁵

Operational Presence & Market Activity

Physical footprint

Ulrich Medical’s published locations identify its headquarters in Ulm, Germany, with operating subsidiaries in the United States, France, and Spain.⁹

The company’s US subsidiary maintains its headquarters in Plano, Texas, and describes operations supporting the American spinal-implant market.^{19, 23}

The French business is based in Toulouse, while ulrich medical España S.L. identifies Madrid as its operating location.^{9, 21}

No directly owned office, production plant, warehouse, support center, or R&D facility in Israel or the occupied territories was identified in the company’s reviewed locations disclosures.^{9, 19, 21}

Israeli third-party presence

Gil Medical’s public Ulrich partner listing provides evidence that the Ulrich brand is represented through an Israeli medical-equipment distributor.⁴

Gil Medical identifies Petach Tikva as its operating location and describes nationwide distribution and customer-support capabilities.^{5, 7}

These disclosures do not independently establish that Ulrich owns or leases Gil Medical’s premises, employs Gil Medical personnel, or operates a separately registered branch at that address.^{4, 7, 22}

Act record - distributor operating location

• Acting entity: Gil Medical Group / Gil Medical Ltd; associated brand: Ulrich Medical; recipient: the Israeli medical-equipment market; location: 21 Gonen Street, Petach Tikva; channel: gilmedical.co.il and an Israeli medical-supplier directory; earliest dated relationship observation: unknown; latest observation: October 2026; status: current public partner representation, with transaction-level continuity unverified; audience: medical institutions and prospective customers.^{4, 7, 8}

Workforce and employment

Ulrich Medical reported in January 2025 that it employed more than 600 people worldwide, including more than 550 at its Ulm headquarters.²⁶

A Eurospine corporate profile independently describes the company as employing more than 650 people worldwide and identifies Germany, the United States, France, and Spain as its principal group locations.¹⁶

The Israeli medical-supplier directory identifies approximately 20 workers for Gil Medical, but these are distributor personnel and cannot be attributed to Ulrich Medical’s own employee headcount.⁸

No public evidence identified establishing employees directly employed by Ulrich Medical in Israel or the occupied territories.^{9, 19, 26}

Israeli tax and registration status

Ulrich’s German corporate imprint identifies a German VAT registration and registrations at the Ulm commercial registry.²²

No public evidence identified of Israeli corporate tax residency, Israeli Preferred Technology Enterprise status, a directly owned Israeli tax registration, or Israeli corporate incorporation attributable to Ulrich Medical.^{9, 22}

Market positioning

Ulrich Medical describes its US business as a significant international growth contributor and identifies Europe as an important market for its contrast-media injectors.^{18, 26}

Its September 2024 announcement identified a 30 percent Spanish market share for contrast-media injectors immediately before establishing its Spanish subsidiary.²⁰

No public evidence identified in the reviewed company disclosures describing Israel as a strategic growth market, regional headquarters, major export market, or dominant national revenue contributor.^{9, 18, 20}

Public-sector customers and procurement

No public evidence identified of a named Israeli government tender, Israeli Ministry of Defense contract, IDF procurement award, or settlement-municipality contract awarded specifically to Ulrich Medical or for identified Ulrich products.^{4, 7, 9}

Settlement-specific operations

Gil Medical states that it provides nationwide service within Israel, but its public Ulrich partner listing does not identify individual Ulrich customers or delivery destinations.^{4, 5}

No public evidence identified of an Ulrich-branded product installed, supplied, maintained, or distributed to a named settlement in the West Bank, East Jerusalem, or Golan Heights.^{4, 5, 7}

Post-July and post-November 2024 observations

The Gil Medical website publicly listed Ulrich as a partner when inspected on 28 October 2026, after both 19 July 2024 and November 2024.⁴

The earliest transaction date, specific shipment history, and continuity of individual commercial transactions across those milestones remain unverified in the retrieved distributor disclosures.^{4, 6}

Corporate Structure & Foundational Ties

Founding history

Ulrich Medical states that Heinrich C. Ulrich founded the enterprise in Ulm, Germany, in 1912.²³

The company’s corporate history describes the transition to fourth-generation family management, including Christoph Ulrich’s assumption of management responsibilities in 2009.¹⁵

No public evidence identified that Ulrich Medical was founded in Israel, originally incorporated in Israel, or acquired an Israeli-origin corporate identity.^{15, 22, 23}

Headquarters and domicile

The company’s registered German operating entity is ulrich GmbH & Co. KG, Buchbrunnenweg 12, 89081 Ulm, Germany.²²

The corporate imprint identifies Ulm commercial-register references HRA 222 and HRB 3209 for the disclosed partnership and corporate structure.²²

The company’s American and international locations disclosures identify Ulm as the longstanding group headquarters.^{9, 19}

Israeli-nexus structural factors

• Founding in Israel: no public evidence identified; the company documents its German founding in 1912.^{15, 23}
• Israeli headquarters or principal management: no public evidence identified; official disclosures identify Ulm, Germany.^{9, 22}
• Israeli corporate tax residency or PTE status: no public evidence identified; the reviewed imprint provides German registration particulars.²²
• Israeli beneficial ownership or control: no public evidence identified; the company describes itself as family-owned and identifies German partnership arrangements.^{22, 23}
• Acquired Israeli operating identity: no public evidence identified; the published subsidiary structure concerns the United States, France, and Spain.^{9, 16}

Management and governance

Ulrich Medical’s management disclosures identify Friedrich von Rechteren as CEO and Chairman of the Management Board from 1 June 2025, succeeding Klaus Kiesel.²⁴

The company identifies Christoph Ulrich as managing partner and Gordon Bittig as CFO and member of the management board.^{22, 27}

The management page also identifies Sven Erdmann in technology and regulation, Steffen Kölsch in operations and quality management, and Cornelia Schweizer in sales and marketing.²⁷

Named-entity search record

• ulrich GmbH & Co. KG - German parent and operating company: Searched Israeli investments, military procurement, settlement activity, Israeli distributors, Israeli tax status, and subsidiary ownership; an Israeli commercial partner, Gil Medical, was identified.^{4, 22}
• ulrich Verwaltungs GmbH - personally liable corporate partner: Searched ownership and Israeli investment relationships; searched, none found.²²
• ulrich medical USA, Inc. - US subsidiary: Searched Israeli operations, Israeli investments, defense procurement, and settlement connections; searched, none found.^{19, 23}
• ulrich medical France SAS - French subsidiary: Searched Israeli operations and investments; searched, none found.^{9, 16}
• ulrich medical España S.L. - Spanish subsidiary: Searched Israeli operations and investments; searched, none found.^{20, 21}
• Gil Medical Group / Gil Medical Ltd - Israeli commercial intermediary: Searched relationship with Ulrich, operating location, settlement activity, and Israeli defense procurement; Ulrich partner listing and Israeli operations identified, with no verified Ulrich-specific military or settlement transaction.^{4, 5, 8}
• Heinrich C. Ulrich - historical founder: Searched Israeli founding, investment, and institutional relationships; searched, none found.²³
• Heiner Ulrich - former family-business leader: Searched Israeli investments and institutional relationships; searched, none found.¹⁵
• Christoph Ulrich - managing partner: Searched Israeli investments, defense-industry directorships, settlement organizations, and Israeli advocacy; searched, none found.^{22, 27}
• Friedrich von Rechteren - CEO and Chairman: Searched Israeli investments, military-industry links, settlement organizations, and state advocacy; searched, none found.²⁴
• Gordon Bittig - CFO: Searched Israeli investments, military-industry links, and financial-sector relationships; searched, none found.^{22, 27}
• Klaus Kiesel - former CEO: Searched Israeli investments, defense-industry relationships, and Israeli public advocacy; searched, none found.^{13, 24}
• Sven Erdmann - technology and regulation executive: Searched Israeli technology partnerships, military applications, and Israeli investments; searched, none found.²⁷
• Steffen Kölsch - operations executive: Searched Israeli procurement, investments, and defense-industry affiliations; searched, none found.²⁷
• Cornelia Schweizer - sales and marketing executive: Searched Israeli distribution partnerships, advocacy, and charitable programs; no separately attributable Israeli act was verified.²⁷
• Christophe Martinez - Spanish subsidiary managing director: Searched Israeli investments, distribution, and settlement-related activity; searched, none found.²¹
• GE Healthcare - international commercial collaborator: Searched target-specific Israeli transactions and military procurement; no Ulrich-specific Israeli act was established through the reviewed collaboration disclosure.¹³
• Bracco Imaging - international commercial collaborator: Searched target-specific Israeli transactions and settlement activity; no Ulrich-specific Israeli act was established through the reviewed collaboration disclosure.¹³
• Synapse Medical - international distributor: Searched Israeli Ulrich transactions and settlement deliveries; searched, none found.^{11, 12}
• Uniphar Medtech - Synapse-associated corporate group: Searched attributable Ulrich transactions involving Israel; searched, none found.¹²
• Hugo Technologies - Synapse technical-service partner: Searched Israel-related Ulrich service activity; searched, none found.¹¹
• EuroAutomation - former Spanish distributor: Searched Israeli investments and transactions attributable to Ulrich; searched, none found.²⁰
• Onventis - procurement technology supplier: Searched Ulrich’s Israeli supplier connections and procurement flows; no Israeli supplier relationship was established through the reviewed customer disclosure.²

Historic named intermediaries and counterparties

Ulrich Medical’s 2024 Spanish announcement identifies EuroAutomation as its former Spanish distributor and documents the transfer of its injector business to Ulrich’s new Spanish subsidiary.²⁰

Onventis identifies ulrich GmbH & Co. KG as a customer of its procurement platform, without disclosing the company’s individual procurement counterparties.²

State and institutional linkages

No public evidence identified of Israeli government share ownership, government-appointed Ulrich board members, an Israeli state golden share, or designation of Ulrich Medical as Israeli critical national infrastructure.^{22, 23, 27}

Structural governance mechanisms

No public evidence identified of an Israeli state veto, Israeli governmental charter restriction, Israeli political-purpose clause, or other governance mechanism structurally connecting the company to Israeli state objectives.^{22, 27}

Corporate public communications

The company’s June 2025 announcement documents the transition from Klaus Kiesel to Friedrich von Rechteren as Chairman and CEO, with Christoph Ulrich continuing as managing partner.²⁴

No public evidence identified of an attributable statement by these executives concerning Israeli settlement activity, Israeli military operations, or the Gaza conflict in the reviewed company communications.^{13, 24, 27}

Reservist policies and charitable contributions

No public evidence identified of an Ulrich Medical Israeli reservist salary policy, IDF support program, military-related donation-matching arrangement, or named settlement-organization donation.^{1, 27}

Profit Repatriation & Economic Contribution

Group revenue

Ulrich Medical reported global turnover of approximately EUR 150 million for 2023 in its July 2024 management announcement.¹³

The company reported EUR 163 million in revenue for 2024, representing approximately 10 percent growth from the preceding year.²⁶

Its April 2026 announcement reported EUR 178 million in 2025 revenue, approximately 10 percent above 2024.¹⁸

Act record - financial disclosures

• Acting entity: ulrich GmbH & Co. KG / Ulrich Medical Group; recipient: public readers and commercial stakeholders; channel: ulrichmedical.com corporate news; period covered: financial years 2023–2025; earliest cited publication: 22 July 2024; latest cited publication: 23 April 2026; status: historical revenue figures publicly available at the research date; Israel-specific allocation: not disclosed in these reports.^{13, 18, 26}

Israel-attributable revenue

The Gil Medical relationship identifies a publicly advertised Israeli commercial route for Ulrich-branded products, but does not disclose sales values, shipment volumes, commission arrangements, or transfer pricing.^{4, 5}

No public evidence identified of a quantified Israel-specific revenue figure, Israeli gross profit, Israeli operating profit, or Israeli market share for Ulrich Medical.^{4, 18, 26}

Profit repatriation

The corporate structure identifies Germany as the location of the parent operating company and identifies overseas subsidiaries in the United States, France, and Spain.^{9, 22}

No public evidence identified of profits generated by Ulrich products in Israel being repatriated through Gil Medical, transferred to an Israeli parent company, or distributed to Israeli beneficial shareholders.^{4, 22, 23}

No public evidence identified specifying the commercial payment terms, distribution margins, royalties, license fees, or tax liabilities arising from the Ulrich–Gil Medical relationship.^{4, 7}

Economic ecosystem role

Gil Medical describes itself as an established Israeli medical-equipment supplier with nationwide distribution and support capabilities and identifies Ulrich among the international manufacturers it represents.^{5, 6}

The Israeli medical-supplier directory corroborates Gil Medical’s presence in the Israeli medical-equipment supply sector.⁸

No public evidence identified characterizing Ulrich Medical itself as a major Israeli employer, Israeli sector anchor, Israeli critical-infrastructure provider, or dominant participant in the Israeli medical-device market.^{9, 18, 26}

Israeli economic relationship - temporal record

• Acting entity: Gil Medical Group / Gil Medical Ltd; associated manufacturer: Ulrich Medical; economic activity: public representation of an international medical-equipment brand in Israel; channel: gilmedical.co.il; earliest confirmed relationship date: unknown; latest public observation: 28 October 2026; status: publicly represented as an existing partnership at the research date, with transaction-level continuity unknown; financial value: undisclosed; customer identities: undisclosed; settlement attribution: no specific settlement transaction verified.^{4, 5, 7}

Post-2024 commercial continuity

Gil Medical’s Ulrich partner page remained publicly accessible in October 2026, establishing that the distributor continued to represent the relationship publicly after July and November 2024.⁴

The reviewed material does not establish the dates of individual Ulrich shipments, commercial payments, or product installations during 2024–2026.^{4, 5}

Additional capital and financial exposure

No public evidence identified of Ulrich Medical financing Israeli sovereign debt, acquiring Israeli operating companies, holding Israeli investment funds, underwriting settlement-related activity, or directly investing in Israeli commercial property.^{9, 22, 23}